PF-4800567 is a drug developed by Pfizer which acts as a selective inhibitor of the enzyme Casein kinase 1 epsilon (CK1-ε) and has mainly been used in the study of the casein kinase 1 enzymes in the regulation of circadian rhythm as well as showing potential neuroprotective effects.
This page contains content from the copyrighted Wikipedia article "PF-4800567"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
